I alt 222 børn deltog i to separate studier til undersøgelse af sikkerheden af pulivizumab, når dete gives som behandling i to sæsoner for RSV.
A total of 222 children were enrolled in two separate studies to examine the safety of palivizumab when it is administered for a second RSV season.